Contrast-enhanced magnetic resonance microangiography reveals remodeling of the cerebral microvasculature in transgenic ArcAβ mice

Journal of Neuroscience

Volumn 32, Issue 5, 2012, Pages 1705-1713

  Klohs, Jan ^a   Baltes, Christof ^a   Princz Kranz, Felicitas ^a   Ratering, David ^a   Nitsch, Roger M ^a   Knuesel, Irene ^a   Rudin, Markus ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; FIBRINOGEN; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE;

AGE; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL DIAMETER; BLOOD VESSEL REMODELING; BRAIN BLOOD VESSEL; CONTROLLED STUDY; FEMALE; IMMUNOHISTOCHEMISTRY; MALE; MICROANGIOGRAPHY; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; TRANSGENIC MOUSE; VASCULAR AMYLOIDOSIS;

AMYLOID BETA-PEPTIDES; ANIMALS; CEREBRAL AMYLOID ANGIOPATHY; CEREBROVASCULAR CIRCULATION; CONTRAST MEDIA; CYTOSKELETAL PROTEINS; FEMALE; FIBRINOGEN; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MICE; MICE, TRANSGENIC; MICROVESSELS; NERVE TISSUE PROTEINS;

EID: 84856667645     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.5626-11.2012     Document Type: Article

References (47)

1. Baltes C, Radzwill N, Bosshard S, Marek D, Rudin M (2009) Micro MRI of the mouse brain using a novel 400 MHz cryogenic quadrature RF probe. NMR Biomed 22:834-842.
2. Beckmann N, Schuler A, Mueggler T, Meyer EP, Wiederhold KH, Staufenbiel M, Krucker T (2003) Age-dependent cerebrovascular abnormalities and blood flow disturbances in APP23 mice modeling Alzheimer's disease. J Neurosci 23:8453-8459.
3. Benveniste H, Einstein G, Kim KR, Hulette C, Johnson GA (1999) Detection of neuritic plaques in Alzheimer's disease by magnetic resonance microscopy. Proc Natl Acad Sci U S A 96:14079-14084.
4. Bolan PJ, Yacoub E, Garwood M, Ugurbil K, Harel N (2006) In vivo micro- MRI of intracortical neurovasculature. Neuroimage 32:62-69.
5. Bouras C, Kövari E, Herrmann FR, Rivara CB, Bailey TL, von Gunten A, Hof PR, Giannakopoulos P (2006) Stereologic analysis of microvascular morphology in the elderly: Alzheimer disease pathology and cognitive status. J Neuropathol Exp Neurol 65:235-244.
6. Boxerman JL, Hamberg LM, Rosen BR, Weisskoff RM (1995) MR contrastdue to intravascular magnetic susceptibility perturbations. Magn Reson Med 34:555-566.
7. Buée L, Hof PR, Bouras C, Delacourte A, Perl DP, Morrison JH, Fillit HM (1994) Pathological alterations of the cerebral microvasculature in Alzheimer's disease and related dementing disorders. Acta Neuropathol 87: 469-480.
8. Cadavid D, Mena H, Koeller K, Frommelt RA (2000) Cerebral beta amyloid angiopathy is a risk factor for cerebral ischemic infarction. A case control study in human brain biopsies. J Neuropathol Exp Neurol 59:768-773.
9. Calhoun ME, Burgermeister P, Phinney AL, Stalder M, Tolnay M, Wiederhold KH, Abramowski D, Sturchler-Pierrat C, Sommer B, Staufenbiel M, Jucker M (1999) Neuronal overexpression of mutant amyloid precursor protein results in prominent deposition of cerebrovascular amyloid. Proc Natl Acad Sci U S A 96:14088-14093.
10. Cortes-Canteli M, Paul J, Norris EH, Bronstein R, Ahn HJ, Zamolodchikov D, Bhuvanendran S, Fenz KM, Strickland S (2010) Fibrinogen and betaamyloid association alters thrombosis and fibrinolysis: a possible contributing factor to Alzheimer's disease. Neuron 66:695-709.
11. de la Torre JC (1997) Hemodynamic consequences of deformed microvessels in the brain in Alzheimer's disease. Ann NY Acad Sci 826:75-91.
12. Dowson JH, Harris SJ (1981) Quantitative studies of the autofluorescence derived from neuronal lipofuscin. J Microsc 123:249-258.
13. El Tannir El Tayara N, Delatour B, Volk A, Dhenain M (2010) Detection of vascular alterations by in vivo magnetic resonance angiography and histology in APP/PS1 mouse model of Alzheimer's disease. MAGMA 23:53-64.
14. Fischer VW, Siddiqi A, Yusufaly Y (1990) Altered angioarchitecture in selected areas of brains with Alzheimer's disease. Acta Neuropathol 79:672-679.
15. Franceschi M, Alberoni M, Bressi S, Canal N, Comi G, Fazio F, Grassi F, Perani D, Volonté MA (1995) Correlations between cognitive impairment, middle cerebral artery flow velocity and cortical glucose metabolism in the early phase of Alzheimer's disease. Dementia 6:32-38.
16. Gilbert JJ, Vinters HV (1983) Cerebral amyloid angiopathy: incidence and complications in the aging brain. I. Cerebral hemorrhage. Stroke 14:915-923.
17. Glenner GG, Henry JH, Fujihara S (1981) Congophilic angiopathy in the pathogenesis of Alzheimer's degeneration. Ann Pathol 1:120-129.
18. Haacke EM, Hopkins A, Lai S, Buckley P, Friedman L, Meltzer H, Hedera P, Friedland R, Klein S, Thompson L, Detterman D, Tkach J, Lewin JS (1994) 2D and 3D high resolution gradient echo functional imaging of the brain: venous contributions to signal in motor cortex studies. NMR Biomed 7:54-62.
19. Haglund M, Passant U, Sjöbeck M, Ghebremedhin E, Englund E (2006) Cerebral amyloid angiopathy and cortical microinfarcts as putative substrates of vascular dementia. Int J Geriatr Psychiatry 21:681-687.
20. Herzig MC, Winkler DT, Burgermeister P, Pfeifer M, Kohler E, Schmidt SD, Danner S, Abramowski D, Stürchler-Pierrat C, Bürki K, van Duinen SG, Maat-Schieman ML, Staufenbiel M, Mathews PM, Jucker M (2004) Abeta is targeted to the vasculature in a mouse model of hereditary cerebral hemorrhage with amyloidosis. Nat Neurosci 7:954-960.
21. Klohs J, Deistung A, Schweser F, Grandjean J, Dominietto M, Waschkies C, Nitsch RM, Knuesel I, Reichenbach J, Rudin M (2011) Detection of cerebral microbleeds with quantitative susceptibility mapping in the ArcAbeta mouse model of cerebral amyloidosis. J Cereb Blood Flow Metab 31:2282-2292.
22. Knobloch M, Konietzko U, Krebs DC, Nitsch RM (2007) Intracellular Abeta and cognitive deficits precede beta-amyloid deposition in transgenic arcAbeta mice. Neurobiol Aging 28:1297-1306.
23. Kouznetsova E, Klingner M, Sorger D, Sabri O, Grossmann U, Steinbach J, Scheunemann M, Schliebs R (2006) Developmental and amyloid plaque-related changes in cerebral cortical capillaries in transgenic Tg2576 Alzheimer mice. Int J Dev Neurosci 24:187-193.
24. Krucker T, Schuler A, Meyer EP, Staufenbiel M, Beckmann N (2004) Magnetic resonance angiography and vascular corrosion casting as tools in biomedical research: application to transgenic mice modeling Alzheimer' s disease. Neurol Res 26:507-516.
25. Lee GD, Aruna JH, Barrett PM, Lei DL, Ingram DK, Mouton PR (2005) Stereological analysis of microvascular parameters in a double transgenic model of Alzheimer's disease. Brain Res Bull 65:317-322.
26. Lin W, Abendschein DR, Celik A, Dolan RP Lauffer RB, Walovitch RC, Haacke EM (1997) Intravascular contrast agent improves magnetic resonance angiography of carotid arteries in minipigs. J Magn Reson Imaging 7:963-971.
27. Majumdar S, Zoghbi SS, Gore JC (1990) Pharmacokinetics of superparamagnetic iron-oxide MR contrast agents in the rat. Invest Radiol 25:771-777.
28. Marchesi VT (2011) Alzheimer's dementia begins as a disease of small blood vessels, damaged by oxidative-induced inflammation and dysregulated amyloid metabolism: implications for early detection and therapy. FASEB J 25:5-13.
29. Merlini M, Meyer EP, Ulmann-Schuler A, Nitsch RM (2011) Vascular β-amyloid and early astrocyte alterations impair cerebrovascular function and cerebral metabolism in transgenic arcAβ mice. Acta Neuropathol 122:293-311.
30. Miao J, Xu F, Davis J, Otte-Höller I, Verbeek MM, Van Nostrand WE (2005) Cerebral microvascular amyloid beta protein deposition induces vascular degeneration and neuroinflammation in transgenic mice expressing human vasculotropic mutant amyloid beta precursor protein. Am J Pathol 167:505-515.
31. Moody DM, Brown WR, Challa VR, Ghazi-Birry HS, Reboussin DM (1997) Cerebral microvascular alterations in aging, leukoaraiosis, and Alzheimer' s disease. Ann NY Acad Sci 26:103-116.
32. Ogawa S, Lee TM (1990) Magnetic resonance imaging of blood vessels at high fields: in vivo and in vitro measurements and image simulation. Magn Reson Med 16:9-18.
33. Ogawa S, Lee TM, Nayak AS, Glynn P (1990) Oxygenation-sensitive contrast in magnetic resonance image of rodent brain at high magnetic fields. Magn Reson Med 14:68-78.
34. Paul J, Strickland S, Melchor JP (2007) Fibrin deposition accelerates neurovascular damage and neuroinflammation in mouse models of Alzheimer' s disease. J Exp Med 204:1999-2008.
35. Portman MA, Cooper TG, Potchen EJ (1992) Physiologic alterations in cranial blood flow demonstrated by magnetic resonance angiography. Invest Radiol 27:240-244.
36. Princz-Kranz FL, Mueggler T, Knobloch M, Nitsch RM, Rudin M (2010) Vascular response to acetazolamide decreases as a function of age in the arcA beta mouse model of cerebral amyloidosis. Neurobiol Dis 40:284-292.
37. Ratering D, Baltes C, Lohmann C, Matter CM, Rudin M (2011) Accurate assessment of carotid artery stenosis in atherosclerotic mice using accelerated high-resolution 3D magnetic resonance angiography. MAGMA 24:9-18.
38. Reese T, Bochelen D, Sauter A, Beckmann N, Rudin M (1999) Magnetic resonance angiography of the rat cerebrovascular system without the use of contrast agents. NMR Biomed 12:189-196.
39. Reichenbach JR, Venkatesan R, Schillinger DJ, Kido DK, Haacke EM (1997) Small vessels in the human brain:MRvenography with deoxyhemoglobin as an intrinsic contrast agent. Radiology 204:272-277.
40. Ruggeri ZM (2007) The role of von Willebrand factor in thrombus formation. Thromb Res 120 [Suppl 1]:S5-S9.
41. Ryu JK, McLarnon JG (2009) A leaky blood-brain barrier, fibrinogen infiltration and microglial reactivity in inflamed Alzheimer's disease brain. J Cell Mol Med 13:2911-2925.
42. Thal DR, Capetillo-Zarate E, Larionov S, Staufenbiel M, Zurbruegg S, Beckmann N (2009) Capillary cerebral amyloid angiopathy is associated with vessel occlusion and cerebral blood flow disturbances. Neurobiol Aging 30:1936-1948.
43. Troprés I, Grimault S, Vaeth A, Grillon E, Julien C, Payen JF, Lamalle L, Décorps M (2001) Vessel size imaging. Magn Reson Med 45:397-408.
44. Underwood RS, Mohiaddin RH (1993) Magnetic resonance imaging of atherosclerotic vascular disease. Am J Hypertens 6:335S-339S.
45. Vriens EM, Kraaier V, Musbach M, Wieneke GH, van Huffelen AC (1989) Transcranial pulsed Doppler measurements of blood velocity in the middle cerebral artery: reference values at rest and during hyperventilation in healthy volunteers in relation to age and sex. Ultrasound Med Biol 15:1-8.
46. Weller RO, Subash M, Preston SD, Mazanti I, Carare RO (2008) Perivascular drainage of amyloid-beta peptides from the brain and its failure in cerebral amyloid angiopathy and Alzheimer's disease. Brain Pathol 18:253-266.
47. Weller RO, Boche D, Nicoll JA (2009) Microvascular changes and cerebral amyloid angiopathy in Alzheimer's disease and their potential impact on therapy. Acta Neuropathol 118:87-102.